CLL Information & Management Archives

CLL/SLL patients have greatly benefited from breakthroughs in understanding the disease’s biology and the resulting new targeted therapies.

Follow-up results from a phase 1/2 trial of acalabrutinib in CLL/SLL patients further confirm that acalabrutinib is safe & effective.

Patients with acalabrutinib had lower discontinuation rates and a prolonged time to discontinuation compared to pts treated with ibrutinib.

Pirtobrutinib can extend the benefits of Bruton tyrosine kinase (BTKi) in patients with CLL/SLL who are resistant to covalent BTKi

Dr. Koffman and Dr. Seymour discuss our latest learnings on how IGHV mutational status affects treatment outcomes.

We discuss enitociclib, an experimental CDK9 inhibitor in development for treating NHL and CLL.

A study that used real-world data to see what treatments are being given to patients with CLL/SLL who have received 2+ lines of therapy

BTK inhibitors have revolutionized the care of CLL/SLL patients and profoundly improved outcomes

The combination of ibrutinib plus venetoclax is an effective first-line treatment for high-risk chronic lymphocytic leukemia (CLL)

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

CLL Information & Management